Dihydroergotamine Mesylate

Dihydroergotamine Mesylate

Cat. No.: PI6190392

Description: Dihydroergotamine mesilate, an ergot alkaloid, is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. It can be administered orally as a tablet, injected or administered as a nasal spray.

Dihydroergotamine Mesylate
Product Details
CAS 6190-39-2
Trade Names D.H.E. 45, Migranal
Synonyms ergotaman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-,(5'α)-, monomethanesulfonate
Molecular Formula C34H41N5O8S
Molecular Weight 679.78
Available Formulations Injectables
Nasal Systemic
Oral Solid
Oral Solid Long-Acting
Technology Plant Extraction
Available DMF/CEP/GMP CEP, EU DMF, Other, US DMF
Appearance Colorless solution

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2